California’s Assembly and Senate have both overwhelmingly passed Senate Bill 598, legislation that creates a pathway for the substitution of interchangeable biologic medicines.
Despite fierce opposition from insurance companies and large pharmacy chains, it is now on its way to the Governor’s desk. It’s critical for him to understand that this issue is one of the highest priorities for patients, healthcare providers and the life sciences industry.
Senate Bill 598 is needed now to update current law and allow pharmacists to automatically substitute a new class of biologic medicines, called biosimilars, for a brand biologic when the biosimilar is deemed interchangeable by the FDA.
If you live or work in California, please send in your support letter today and let Governor Brown know how important this bill is to you!